Clinical trial · Observational
A Biological Sample Collection Protocol of Women With and Without Breast Cancer
A Biological Sample Collection Protocol of Women With and Without Breast Cancer: Hoosier Oncology Group Study BRE06-120 for the Analytical Proteomics Team
NCT00472589CI-TRIAL-00023608completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this trial is to collect plasma, serum, whole blood and tissue samples from women with breast cancer and plasma, serum, whole blood from healthy women, which will be made available to researchers for biomarker analysis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- 1
- description
- Healthy women
- label
- 2
- description
- Women with breast cancer
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: FOR WOMEN WITH BREAST CANCER * Histologically or cytologically confirmed invasive malignancy or ductal carcinoma in situ of the breast. * Preparing to begin a new regimen for breast cancer (adjuvant, locally recurrent, any line metastatic). * Female. * Age \> 18 years at the time of consent. * Written informed consent and HIPAA authorization for release of personal health information. FOR HEALTHY VOLUNTEERS * No known history of invasive malignancy or ductal carcinoma in situ. Volunteers must not have prior history of malignancy in the past 5 years with the exception of basal cell and squamous cell carcinoma of the skin. Other cancers with low potential for metastasis, such as in situ cancers (e.g., Grade 1, TA TCC (low grade superficial bladder cancer), colonic polyp with focus of adenocarcinoma) can also be enrolled as healthy volunteers. * Female * Age \> 18 years at the time of consent. * Written informed consent and HIPAA authorization for release of personal health information. Exclusion Criteria: * Females must not be pregnant.
References
Publications (0)
Data not yet available
No reference posted for this study.